Document is current
Any future updates will be listed below
-
Authors
Jaber, Samir
De Jong, Audrey
Schaefer, Maximilian S.
Zhang, Jiaqiang
Ma, Xiaowen
Hao, Xinrui
Zhou, Shujing
Lv, Shang
Banner-Goodspeed, Valerie
Niu, Xiuhua
Sfara, Thomas
Talmor, Daniel
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05495841 at ClinicalTrials.govDocuments that mention this clinical trial
Preoxygenation with standard facemask combining apnoeic oxygenation using high flow nasal cannula versuss standard facemask alone in patients with and without obesity: the OPTIMASK international study
https://doi.org/10.1186/s13613-023-01124-x
- License Information
-
More Information
Article History
Received: 7 February 2023
Accepted: 25 March 2023
First Online: 4 April 2023
Declarations
:
: The appropriate ethical approval was obtained at each participating institution. The need for informed consent was waived at three centres on the basis that the study did not require any research procedures other than passive data collection, while one centre required prospective informed consent from participants. The final database was de-identified. The research was carried out in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: Pr. Jaber reports receiving consulting fees from Drager, Medtronic, Mindray, Fresenius, Baxter, and Fisher & Paykel. Pr De Jong reports receiving remuneration for presentations from Medtronic, Drager and Fisher & Paykel. Pr Talmor has received funding from CLEW, Hamilton Medical, Mindray and the US National Institutes of Health. Dr. Schaefer has received funding from Merck, speaker fees from Mindray and Fisher & Paykel and philanthropic, unrestricted funding from Jeff and Judy Buzen. No competing interests are reported for other authors.
